Veeva CRM-Approved Email App Gets Bigger As Major Ad Agencies Invest Early

Giant Healthcare Advertising and DraftFCB Healthcare are among the first healthcare advertising companies to invest in the new approved messaging solution from Veeva Systems – well ahead of its general release. These early partners are developing content for Veeva CRM Approved Email, first presented today to an audience of 700 executives from 100 life science companies at Veeva’s Global Customer Summit. The new solution is designed to increase the productivity of life science field representatives by enabling them to email approved content in a compliant and cost-effective manner directly to clients.

(Logo: http://photos.prnewswire.com/prnh/20120425/527164 )

(Photo: http://photos.prnewswire.com/prnh/20130507/613107 )

“For over a decade, our customers in unregulated industries have taken full advantage of email as a means of reaching customers,” said Dana maiman, CEO and President of DraftFCB Healthcare, a global integrated marketing communications agency focused on healthcare. “By finally equipping life science companies with an integrated solution that enables salespeople to send emails to their customers, Veeva is transforming the face of customer interactions overnight. There is no doubt that we wanted to be one of the first agencies able to deliver content for approved emails. “

Historically, life sciences field teams have limited themselves to communicating with clients in person using only approved step-by-step helpers due to the risks associated with emailing unapproved or non-compliant content. With Veeva CRM Approved Email, the life sciences industry can now increase and improve the quality of customer interactions, reach more low-access and invisible healthcare professionals globally, and provide more drug information. relevant, all without increasing the size of the sales force.

“With the proliferation of information channels and sources, physicians expect communications on their terms,” ​​said Jonathan peischl, SVP, Director of Innovation and Digital Marketing at Giant Creative / Strategy, winner of the 2013 Agency of the Year award from MedAdNews. “With Veeva CRM Approved Email, our customers can now realize the vision of multi-channel customer interactions.”

Approved Email supports life science users from content creation to execution with Veeva’s market-leading iRep app for CRM and integrated CLM for iPad. It ensures that only the most up-to-date and approved content is sent to customers, while storing the full history of every interaction in Veeva CRM to provide a complete customer view. Built-in controls, such as email subscribe / unsubscribe management and off-label restrictions, help further ensure regulatory compliance. And with the professional email templates provided by the major advertising companies, users can personalize highly engaging emails. It is the first solution that enables regulatory compliant e-mail communication between salespeople and healthcare professionals.

Giant and DraftFCB Healthcare are members of the Veeva Web program and have achieved Veeva Web Approved status for their work with iRep. The Veeva Web program is a global network of content providers that has grown to over 100 agencies in just over a year. This ecosystem of Veeva’s web partners will be formed to support content creation for approved emails over the next two months.

Veeva CRM Approved Email is intended for general availability in June 2013.

The company also today announced Veeva Network, the newest addition to Veeva’s commercial suite for life sciences. Available in late 2013, Veeva Network combines the services of Healthcare Professionals (HCPs), Healthcare Organizations (HCOs), Affiliations and Master Data, Software and Management into a seamlessly integrated solution with Veeva CRM.

About Veeva Systems

Veeva Systems is a leader in cloud-based software for the global life science industry. Committed to innovation, product excellence and customer success, Veeva has more than 150 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechnology. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia cream, Barcelona, Budapest, London, Paris, Beijing, Shanghai and Tokyo. For more information visit http://www.veevasystems.com.

Copyright (c) 2013 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems has other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.

Media contacts:

Lisa Barbadora
Veeva Systems, Inc.
[email protected]

SOURCE Veeva Systems


Source link

June J. Lopez

Leave a Reply

Your email address will not be published.